Carpal Tunnel Syndrome
Conditions
Keywords
Fu's Subcutaneous Needling, carpal tunnel syndrome
Brief summary
The goal of this clinical trial is to evaluate the efficacy of Fu's Subcutaneous Needling (FSN) in carpal tunnel syndrome (CTS). The main questions it aims to answer are: * Dose FSN improve the symptoms of CTS? * Dose FSN decrease cross section area of median nerve in CTS patients? * Dose FSN have the effect of electrophysiology exam in CTS patients? Participants will receive wrist splinting and FSN treatment respectively. Researchers will compare wrist splinting group with FSN group to see if FSN being effective for CTS.
Interventions
DEVICEwrist splinting
standard wrist splinting at night for 2 weeks
DEVICEFSN
FSN is a single-use disposable needle(Trocar Acupuncture Needle, Nanjing FSN Medical Co. , Ltd, China.). The needle body is solid, and covered with a plastic tube. The needle penetrates the skin with insertion device. Under the guidance of ultrasound, the needle enter the loose subcutaneous layer obliquely without penetrating into the muscle. This is the difference from traditional acupuncture. The insertion point is midpoint of the anterior forearm. The needle tip is toward the carpal tunnel. After the needle is inserted, SM and RA are performed. The frequency of SM is 200 times in two minutes. The method of SM is to make a horizontal fan swaying with the base of the needle as the fulcrum. RA is performed while SM-slowly make a fist for 10 seconds and then relax for 5 seconds. Eight times of RA in two minutes. After the FNS treatment, the needle was withdrawn.
Sponsors
China Medical University Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
20 Years to 85 Years
Healthy volunteers
Yes
Inclusion criteria
1. Male or female aged 20-85 years old. 2. Meet the diagnosis of mild to moderate carpal tunnel syndrome. 3. If the patient has carpal tunnel syndrome in both hands, choose the side with mild or moderate carpal tunnel syndrome. 4. After being explained, join the trial voluntarily and sign the subject's consent form.
Exclusion criteria
1. Caused by trauma or mass lesion. 2. Thenar muscle atrophy. 3. Electrophysiological examination revealed severe CTS. 4. Chronic kidney disease, rheumatoid arthritis, abnormal thyroid function, diabetes. 5. Psychiatric history or incapable of cooperating with the investigator. 6. Pregnancy. 7. History of substance abuse or long-term steroid use. 8. History of median nerve surgery. 9. Those who do not sign the consent form.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change of electrophysiology exam | Change from baseline at one month after treatment. | Exam of motor latency |
| Change of cross section area of median nerve in ultrasound | Change from baseline at one month after treatment | cross section area of median nerve |
| Change of Boston Carpal Tunnel Questionnaire (BCTQ) | Change from baseline at one month after treatment. | BCTQ |
Countries
Taiwan
Contacts
Primary ContactChih Ying Wu, MD
Outcome results
None listed